{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T09:17:03Z","timestamp":1787995023548,"version":"build-2784847793"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Capital\u2019s Funds for Health Improvement and Research","award":["2024-1-4065"],"award-info":[{"award-number":["2024-1-4065"]}]},{"name":"China Association of Chinese Medicine","award":["2024-QNQS-07"],"award-info":[{"award-number":["2024-QNQS-07"]}]},{"DOI":"10.13039\/501100010036","name":"China-Japan Friendship Hospital Youth Science and Technology Excellence Project","doi-asserted-by":"publisher","award":["ZRJY2024-GG08"],"award-info":[{"award-number":["ZRJY2024-GG08"]}],"id":[{"id":"10.13039\/501100010036","id-type":"DOI","asserted-by":"publisher"}]},{"name":"High Level Hospital Clinical Research Funding Specia Project of China-Japan Friendship Hospital","award":["2025-NHLHCRF-PY-36"],"award-info":[{"award-number":["2025-NHLHCRF-PY-36"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s10067-026-08311-8","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T14:25:01Z","timestamp":1784730301000},"page":"5653-5666","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical characteristics and prognosis of primary Sj\u00f6gren\u2019s disease patients with hypocomplementemia: reduced C3 is independently associated with new-onset peripheral cytopenias"],"prefix":"10.1007","volume":"45","author":[{"given":"Zihan","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunxin","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiya","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuanyi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bojie","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haojia","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijiang","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingwen","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2454-2168","authenticated-orcid":false,"given":"Jing","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,22]]},"reference":[{"issue":"10","key":"8311_CR1","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1056\/NEJMcp1702514","volume":"378","author":"X Mariette","year":"2018","unstructured":"Mariette X, Criswell LA (2018) Primary Sj\u00f6gren\u2019s syndrome. N Engl J Med 378(10):931\u2013939","journal-title":"N Engl J Med"},{"issue":"6","key":"8311_CR2","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1136\/ard.2009.110619","volume":"69","author":"R Seror","year":"2009","unstructured":"Seror R, Ravaud P, Bowman SJ, Baron G, Tzioufas A, Theander E et al (2009) EULAR Sjogren\u2019s syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren\u2019s syndrome. Ann Rheum Dis 69(6):1103\u20131109","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"8311_CR3","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1097\/MD.0b013e318181e6af","volume":"87","author":"M Ramos-Casals","year":"2008","unstructured":"Ramos-Casals M, Solans R, Rosas J, Camps T, Gil A, Del Pino-Montes J et al (2008) Primary Sj\u00f6gren syndrome in Spain: clinical and immunologic expression in 1010 patients. Medicine (Baltimore) 87(4):210\u20139","journal-title":"Medicine (Baltimore)"},{"issue":"7","key":"8311_CR4","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1007\/s10067-022-06135-w","volume":"41","author":"W Lin","year":"2022","unstructured":"Lin W, Xin Z, Wang J, Ren X, Liu Y, Yang L et al (2022) Hypocomplementemia in primary Sjogren\u2019s syndrome: association with serological, clinical features, and outcome. Clin Rheumatol 41(7):2091\u20132102","journal-title":"Clin Rheumatol"},{"issue":"5","key":"8311_CR5","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1093\/rheumatology\/ket427","volume":"53","author":"C Baldini","year":"2013","unstructured":"Baldini C, Pepe P, Quartuccio L, Priori R, Bartoloni E, Alunno A et al (2013) Primary Sjogren\u2019s syndrome as a multi-organ disease: impact of the serological profile on the clinical presentation of the disease in a large cohort of Italian patients. Rheumatology (Oxford) 53(5):839\u201344","journal-title":"Rheumatology (Oxford)"},{"issue":"9","key":"8311_CR6","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/ni.1923","volume":"11","author":"D Ricklin","year":"2010","unstructured":"Ricklin D, Hajishengallis G, Yang K, Lambris JD (2010) Complement: a key system for immune surveillance and homeostasis. Nat Immunol 11(9):785\u2013797","journal-title":"Nat Immunol"},{"issue":"10","key":"8311_CR7","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/nri2620","volume":"9","author":"PF Zipfel","year":"2009","unstructured":"Zipfel PF, Skerka C (2009) Complement regulators and inhibitory proteins. Nat Rev Immunol 9(10):729\u2013740","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"8311_CR8","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1093\/rheumatology\/keh407","volume":"44","author":"M Ramos-Casals","year":"2005","unstructured":"Ramos-Casals M, Brito-Zer\u00f3n P, Yag\u00fce J, Akasbi M, Bautista R, Ruano M et al (2005) Hypocomplementaemia as an immunological marker of morbidity and mortality in patients with primary Sjogren\u2019s syndrome. Rheumatology (Oxford) 44(1):89\u201394","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"8311_CR9","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12868-018-0427-y","volume":"19","author":"W Ye","year":"2018","unstructured":"Ye W, Chen S, Huang X, Qin W, Zhang T, Zhu X et al (2018) Clinical features and risk factors of neurological involvement in Sj\u00f6gren\u2019s syndrome. BMC Neurosci 19(1):26","journal-title":"BMC Neurosci"},{"issue":"2","key":"8311_CR10","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/1756-185X.13429","volume":"22","author":"J Luo","year":"2019","unstructured":"Luo J, Xu S, Lv Y, Huang X, Zhang H, Zhu X et al (2019) Clinical features and potential relevant factors of renal involvement in primary Sj\u00f6gren\u2019s syndrome. Int J Rheum Dis 22(2):182\u2013190","journal-title":"Int J Rheum Dis"},{"issue":"2","key":"8311_CR11","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1093\/rheumatology\/ket349","volume":"53","author":"M Ramos-Casals","year":"2013","unstructured":"Ramos-Casals M, Brito-Zer\u00f3n P, Solans R, Camps M-T, Casanovas A, Sope\u00f1a B et al (2013) Systemic involvement in primary Sjogren\u2019s syndrome evaluated by the EULAR-SS disease activity index: analysis of 921 Spanish patients (GEAS-SS Registry). Rheumatology (Oxford) 53(2):321\u2013331","journal-title":"Rheumatology (Oxford)"},{"key":"8311_CR12","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000003766","author":"S Fragkioudaki","year":"2016","unstructured":"Fragkioudaki S, Mavragani CP, Moutsopoulos HM (2016) Predicting the risk for lymphoma development in Sjogren syndrome: an easy tool for clinical use. Medicine (Baltimore). https:\/\/doi.org\/10.1097\/MD.0000000000003766","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"8311_CR13","doi-asserted-by":"publisher","first-page":"112","DOI":"10.5152\/eurjrheum.2020.19132","volume":"7","author":"P Jord\u00e1n-Gonz\u00e1lez","year":"2020","unstructured":"Jord\u00e1n-Gonz\u00e1lez P, Gago-Pi\u00f1ero R, Varela-Rosario N, P\u00e9rez-R\u00edos N, Vil\u00e1 LM (2020) Characterization of a subset of patients with primary Sj\u00f6gren\u2019s syndrome initially presenting with C3 or C4 hypocomplementemia. Eur J Rheumatol 7(3):112\u2013117","journal-title":"Eur J Rheumatol"},{"issue":"6","key":"8311_CR14","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1136\/ard.61.6.554","volume":"61","author":"C Vitali","year":"2002","unstructured":"Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE et al (2002) Classification criteria for Sj\u00f6gren\u2019s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 61(6):554\u2013558","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"8311_CR15","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1002\/art.39859","volume":"69","author":"CH Shiboski","year":"2017","unstructured":"Shiboski CH, Shiboski SC, Seror R, Criswell LA, Labetoulle M, Lietman TM et al (2017) 2016 American College of Rheumatology\/European League Against Rheumatism classification criteria for primary sj\u00f6gren\u2019s syndrome: a consensus and data-driven methodology involving three international patient cohorts. Arthritis & rheumatology (Hoboken, NJ) 69(1):35\u201345","journal-title":"Arthritis & rheumatology (Hoboken, NJ)"},{"key":"8311_CR16","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2014-000022","author":"R Seror","year":"2015","unstructured":"Seror R, Bowman SJ, Brito-Zeron P, Theander E, Bootsma H, Tzioufas A et al (2015) EULAR Sj\u00f6gren\u2019s syndrome disease activity index (ESSDAI): a user guide. RMD Open. https:\/\/doi.org\/10.1136\/rmdopen-2014-000022","journal-title":"RMD Open"},{"issue":"7","key":"8311_CR17","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1002\/art.30381","volume":"63","author":"TE Daniels","year":"2011","unstructured":"Daniels TE, Cox D, Shiboski CH, Schiodt M, Wu A, Lanfranchi H et al (2011) Associations between salivary gland histopathologic diagnoses and phenotypic features of Sjogren\u2019s syndrome among 1,726 registry participants. Arthritis Rheum 63(7):2021\u20132030","journal-title":"Arthritis Rheum"},{"issue":"2","key":"8311_CR18","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s00296-013-2885-y","volume":"34","author":"G Sudzius","year":"2013","unstructured":"Sudzius G, Mieliauskaite D, Siaurys A, Viliene R, Butrimiene I, Characiejus D et al (2013) Could the complement component C4 or its fragment C4d be a marker of the more severe conditions in patients with primary Sj\u00f6gren\u2019s syndrome? Rheumatol Int 34(2):235\u2013241","journal-title":"Rheumatol Int"},{"key":"8311_CR19","doi-asserted-by":"publisher","first-page":"359","DOI":"10.2147\/IJGM.S346188","volume":"15","author":"M Zhou","year":"2022","unstructured":"Zhou M, Yuan F (2022) Hypocomplementemia in Primary Sjogren\u2019s syndrome: a retrospective study of 120 treatment-naive Chinese patients. Int J Gen Med 15:359\u2013366","journal-title":"Int J Gen Med"},{"issue":"19","key":"8311_CR20","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000037909","volume":"103","author":"W Yang","year":"2024","unstructured":"Yang W (2024) Comprehensive analysis of the clinical manifestations and hematological parameters associated with secondary immune thrombocytopenia in patients with primary Sj\u00f6gren syndrome: an observational study. Medicine 103(19)","journal-title":"Medicine"},{"issue":"1","key":"8311_CR21","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41375-021-01482-0","volume":"36","author":"MZ Ratajczak","year":"2021","unstructured":"Ratajczak MZ, Kucia M (2021) Hematopoiesis and innate immunity: an inseparable couple for good and bad times, bound together by an hormetic relationship. Leukemia 36(1):23\u201332","journal-title":"Leukemia"},{"issue":"5","key":"8311_CR22","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s10067-009-1366-x","volume":"29","author":"J-G Zhou","year":"2010","unstructured":"Zhou J-G, Qing Y-F, Jiang L, Yang Q-B, Luo W-F (2010) Clinical analysis of primary Sj\u00f6gren\u2019s syndrome complicating anemia. Clin Rheumatol 29(5):525\u2013529","journal-title":"Clin Rheumatol"},{"issue":"11","key":"8311_CR23","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1007\/s10067-015-3081-0","volume":"34","author":"W Wen","year":"2015","unstructured":"Wen W, Liu Y, Zhao C, Sun X, Zhang C, Li Z (2015) Clinical and serologic features of primary Sj\u00f6gren\u2019s syndrome concomitant with autoimmune hemolytic anemia: a large-scale cross-sectional study. Clin Rheumatol 34(11):1877\u20131884","journal-title":"Clin Rheumatol"},{"issue":"12","key":"8311_CR24","doi-asserted-by":"publisher","first-page":"4955","DOI":"10.1007\/s10067-025-07719-y","volume":"44","author":"H Liang","year":"2025","unstructured":"Liang H, Long M, Tie S, Dong S, Duan L, Wang J et al (2025) Clinical characteristics and risk factors for the bidirectional association between immune thrombocytopenia and Sj\u00f6gren\u2019s syndrome. Clin Rheumatol 44(12):4955\u20134963","journal-title":"Clin Rheumatol"},{"key":"8311_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.684999","volume":"12","author":"W Du","year":"2021","unstructured":"Du W, Han M, Zhu X, Xiao F, Huang E, Che N et al (2021) The multiple roles of B cells in the pathogenesis of Sj\u00f6gren\u2019s syndrome. Front Immunol 12","journal-title":"Front Immunol"},{"key":"8311_CR26","doi-asserted-by":"publisher","DOI":"10.1684\/ecn.2024.0496","author":"Y Li","year":"2024","unstructured":"Li Y, Zhang J, Liu X, Ganesan K, Shi G (2024) Identification of inflammatory markers as indicators for disease progression in primary Sj\u00f6gren syndrome. Eur Cytokine Netw. https:\/\/doi.org\/10.1684\/ecn.2024.0496","journal-title":"Eur Cytokine Netw"},{"issue":"22","key":"8311_CR27","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1182\/blood-2015-06-640995","volume":"126","author":"RA Brodsky","year":"2015","unstructured":"Brodsky RA (2015) Complement in hemolytic anemia. Blood 126(22):2459\u20132465","journal-title":"Blood"},{"issue":"6","key":"8311_CR28","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/s41584-021-00605-2","volume":"17","author":"GM Verstappen","year":"2021","unstructured":"Verstappen GM, Pringle S, Bootsma H, Kroese FGM (2021) Epithelial-immune cell interplay in primary Sj\u00f6gren syndrome salivary gland pathogenesis. Nat Rev Rheumatol 17(6):333\u2013348","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"8311_CR29","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/cr.2009.139","volume":"20","author":"JR Dunkelberger","year":"2009","unstructured":"Dunkelberger JR, Song W-C (2009) Complement and its role in innate and adaptive immune responses. Cell Res 20(1):34\u201350","journal-title":"Cell Res"},{"issue":"7","key":"8311_CR30","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.4049\/jimmunol.138.7.2095","volume":"138","author":"ME Sanders","year":"1987","unstructured":"Sanders ME, Alexander EL, Koski CL, Frank MM, Joiner KA (1987) Detection of activated terminal complement (C5b-9) in cerebrospinal fluid from patients with central nervous system involvement of primary Sjogren\u2019s syndrome or systemic lupus erythematosus. J Immunol 138(7):2095\u20132099","journal-title":"J Immunol"},{"issue":"1","key":"8311_CR31","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s12026-016-8844-4","volume":"65","author":"AV Goules","year":"2017","unstructured":"Goules AV, Tzioufas AG (2017) Primary Sj\u00f6gren\u2019s syndrome: clinical phenotypes, outcome and the development of biomarkers. Immunol Res 65(1):331\u2013344","journal-title":"Immunol Res"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-08311-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-026-08311-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-08311-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T08:35:01Z","timestamp":1787992501000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-026-08311-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,22]]},"references-count":31,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["8311"],"URL":"https:\/\/doi.org\/10.1007\/s10067-026-08311-8","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,22]]},"assertion":[{"value":"17 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"None.","order":1,"name":"Ethics","label":"Disclosures","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}}]}}